{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:40:27Z","timestamp":1785930027675,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jmoldx.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T21:28:47Z","timestamp":1545168527000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["t(3;8)(q26.2;q24) Often Leads to MECOM\/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and\/or Disease Progression"],"prefix":"10.1016","volume":"21","author":[{"given":"Guilin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7110-3814","authenticated-orcid":false,"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1815-7666","authenticated-orcid":false,"given":"Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokce","family":"Toruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-9651","authenticated-orcid":false,"given":"Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Doty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-9945","authenticated-orcid":false,"given":"Zhenya","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2018.10.005_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2002-05-1459","article-title":"High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients","volume":"101","author":"Barjesteh van Waalwijk van Doorn-Khosrovani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib2","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/sj.emboj.7600679","article-title":"Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression","volume":"24","author":"Yuasa","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib3","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2217\/fon.15.64","article-title":"3q26\/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review","volume":"11","author":"De Braekeleer","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1079-9796(03)00159-1","article-title":"The role of EVI1 in normal and leukemic cells","volume":"31","author":"Buonamici","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcmd.2014.01.002","article-title":"The role of\u00a0EVI1 in myeloid malignancies","volume":"53","author":"Glass","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.stem.2008.06.002","article-title":"Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells","volume":"3","author":"Goyama","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1349-7006.2009.01152.x","article-title":"Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies","volume":"100","author":"Goyama","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib8","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1200\/JCO.2010.29.2771","article-title":"Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)\/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia","volume":"28","author":"Lugthart","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib9","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2009.26.0646","article-title":"High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities","volume":"28","author":"Groschel","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2141.2001.02569.x","article-title":"EVI1 expression in acute myeloid leukaemia","volume":"112","author":"Langabeer","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/bjh.13898","article-title":"Review: aberrant EVI1 expression in acute myeloid leukaemia","volume":"172","author":"Hinai","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib12","first-page":"130","article-title":"Acute myeloid leukemia with recurrent genetic abnormalities. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissue","author":"Arber","year":"2017"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3324\/haematol.2013.096420","article-title":"Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)\/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study","volume":"99","author":"Rogers","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1309\/AJCP48AJDCKTHUXC","article-title":"Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia","volume":"136","author":"Cui","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/modpathol.2010.210","article-title":"De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification","volume":"24","author":"Sun","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41379-018-0014-x","article-title":"Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome","volume":"31","author":"Kurt","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cancergencyto.2005.10.007","article-title":"Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia","volume":"166","author":"Lin","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cancergencyto.2009.04.025","article-title":"Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24)","volume":"193","author":"Lin","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib19","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3109\/10428194.2013.878460","article-title":"Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and\u00a0review of the literature","volume":"55","author":"Xu","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00277-016-2595-0","article-title":"Acute myeloid leukemia with t(3;8)(q26;q24) complicated by diabetes insipidus","volume":"95","author":"Kubota","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.thj.6200143","article-title":"Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features","volume":"3","author":"Charrin","year":"2002","journal-title":"Hematol J"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib22","first-page":"315","article-title":"Acute myeloid leukemia with t (3;8) (q26.2;q24), a simple variant of 3q26.2\/EVI1 translocation","volume":"58","author":"Sato","year":"2017","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-4608(87)90251-2","article-title":"A case of myelodysplastic syndrome with high platelet counts and a t(3;8)(q26;q24)","volume":"27","author":"Mertens","year":"1987","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3324\/haematol.2018.191148","article-title":"Persistent IDH1\/2 mutation in remission can predict relapse in patients with acute myeloid leukemia","volume":"104","author":"Ok","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12185-009-0375-5","article-title":"Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome","volume":"90","author":"Isoda","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib26","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","article-title":"Advances in the understanding of MYC-induced lymphomagenesis","volume":"149","author":"Klapproth","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cancergen.2015.06.004","article-title":"Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation","volume":"208","author":"Ohanian","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cancergencyto.2007.05.007","article-title":"Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24)","volume":"177","author":"Lennon","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/JTO.0000000000000202","article-title":"Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma","volume":"9","author":"Riquelme","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-014-0068-2","article-title":"8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia","volume":"7","author":"Chinen","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-015-0223-4","article-title":"Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia","volume":"8","author":"Zeng","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hon.2279","article-title":"Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival","volume":"35","author":"Mughal","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cancergen.2016.05.072","article-title":"Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype","volume":"209","author":"Huh","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12094-012-0926-8","article-title":"MYC oncogene in myeloid neoplasias","volume":"15","author":"Delgado","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib37","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib38","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/MCB.24.7.2890-2904.2004","article-title":"Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells","volume":"24","author":"Muller-Tidow","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib39","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2005-02-0734","article-title":"c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations","volume":"106","author":"Luo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.10.005_bib40","doi-asserted-by":"crossref","first-page":"14483","DOI":"10.1073\/pnas.0605245103","article-title":"Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor","volume":"103","author":"Sloand","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157818302976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157818302976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:13:01Z","timestamp":1761502381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157818302976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1525157818302976"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2018.10.005","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"t(3;8)(q26.2;q24) Often Leads to MECOM\/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and\/or Disease Progression","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}